Senior Engineer II, Manufacturing Science and Technology

Welcome to an inspired career at Halozyme Hypercon™, a wholly‑owned subsidiary of Halozyme Therapeutics, Inc. We are reinventing the patient experience and building the future of drug delivery. We are passionate about the important work we do, constantly strive to do more, and embrace transformation to innovate for the future. We do this together as One Team – we rise by lifting others up and believe in the power of working together for the collective win.

That’s why we need you—to help us make a significant impact by taking on increasingly complex challenges, leaping beyond the status quo, advancing our mission, and making our One Team culture thrive.

As a Senior Engineer II, Manufacturing Science and Technology, you’ll be part of a culture that welcomes diversity, thinks differently to solve problems, works collaboratively as one team, and delivers meaningful innovations that impact people’s lives.

Halozyme Hypercon is seeking a talented, enthusiastic, and experienced Senior Engineer II, Manufacturing Science and Technology to execute technology transfer and continuous process improvements for our patented and proprietary Hypercon™ formulation process. This role reports to the Sr. Director, Manufacturing Science & Technology and will support the company with multiple technology transfers and routine manufacturing process support at global CDMOs and business partner manufacturing sites.

The role operates in a highly matrixed environment, managing stakeholders cross‑functionally both internally and externally. Your work will involve several technology transfer programs in parallel as the company executes its 5‑year manufacturing strategy for projected growth. You will serve as an interface between Program Management, Analytical & Process Development, Quality, Supply Chain, Engineering, and Manufacturing for internal, partner, and CDMO stakeholders.

You will participate in cross‑functional teams to successfully accomplish goals and objectives, while continuously improving manufacturing supply and process performance. Global travel up to 25% of time may be required during start‑up of new manufacturing sites to support technology transfer and batch manufacturing. Lean Six Sigma methodologies will be leveraged to create, implement, measure, and report on key performance indicators (KPIs) for manufacturing performance.

It is essential that you thrive in a fast‑paced and dynamic environment and be a key player in the company’s growth.

• Perform all duties according to the company’s core values, policies, and applicable regulations.
• As a member of the MS&T Team, be a change leader to develop and implement innovative approaches to meet the challenges of the rapidly growing business.
• Responsible for technology transfer execution and routine manufacturing support for bulk aseptic formulation and filling processes from Phase I clinical through commercialization.
• Create technology transfer plans, campaign summary reports, process change documentation to support change controls, and CMC support documentation.
• Lead and own process and manufacturing risk assessments with mitigation action plans.
• Review engineering drawings, P&IDs, automation control modules, batch records, process control and validation strategies.
• Partner closely with stakeholders to ensure internal & external production plans and capacity are aligned with clinical demand needs.
• Support manufacturing network during regulatory site inspections.
• Partner with PM and IT functions to implement new technologies for data analysis and process monitoring.

• B.S. Degree in Engineering/Sciences is required;
  Advanced M.S./PhD degree in Engineering is a plus consideration.
• Minimum of 8 years of experience working in a cGMP/cGCP environment is required, preferably working in biologics or cell & gene therapy within the biopharmaceutical industry. Preferred experience should be a combination of work experience in Manufacturing, MS&T, Technical Operations, and/or Development.
• Minimum of 5 years supporting process technology transfers and new manufacturing site start‑up is strongly preferred.
• Minimum of 5…